Institute Of "The Borgess Heart" has been named an Aetna Institute for installation of quality cardiac care for the comprehensive treatment of cardiovascular disease. Aetna makes information on the quality and cost of health services available to its members, so they make informed decisions about their health needs.
In line with this objective, Aetna recognizes hospitals and its network, provide specialized clinical services for specific medical conditions. The facilities are known for their unique expertise in providing systematic evidence-based, safe care selected. "We are proud to have achieved this recognition by Aetna," said Paul Spaude, president and CEO, Borgess Health.
"Our status Aetna Institute for Quality reflects the heritage of the Borgess Heart Institute as a leading heart of southwestern Michigan's health care provider. The Borgess Heart Institute is a leading innovator in cardiac care is. It contains a large state of the art cardiovascular laboratory that could offer one of the first coronary angioplasty in the United States.
All rooms are private cardiac short stay. Three surgical suites dedicated to cardiac surgery. Hospital care is provided with two units of cardiac care and a complete surveillance of 48 intensive care beds. The Borgess Heart Institute is also home to one of the first stand-alone cardiac rehabilitation in America. Cardiovascular Research, Borgess Research Institute supported the development of improved stents, which are currently worldwide used in 80 countries.